Article Sidebar

Download
PDF
Statistic
Read Counter : 0 Download : 0

Downloads

Download data is not yet available.

Main Article Content

Abstract

ABSTRACT
Introduction. Human papillomavirus (HPV) vaccination is the primary strategy for preventing cervical cancer. However, vaccination coverage remains low in Cameroon. This study aimed to identify women's perceived barriers to HPV vaccination among girls aged 9–14 years and to propose strategies to improve vaccine uptake in the Dschang and Foumbot health districts. Methods. A quantitative cross-sectional study was conducted from August 2025 to January 2026 among 110 mothers or guardians of girls aged 9–14 years. Data were collected through face-to-face interviews using a pretested semi-structured questionnaire and analyzed with RStudio using descriptive statistics and Pearson’s chi-square test, with statistical significance set at p < 0.05. Results. Overall, 60% of participants reported that their daughters had not received the HPV vaccine. The main barriers identified were lack of information (21.8%), concerns about vaccine safety (30.9%), cultural or religious beliefs, distance to vaccination centers (36.4%), and vaccine unavailability (34.6%). Healthcare provider recommendations were the main factor influencing vaccination decisions (40%). School-based vaccination programs (56.4%) and strengthened awareness campaigns (65.5%) were the most frequently proposed strategies to improve vaccine uptake. Higher levels of information, discussions with healthcare providers, and better access to vaccination services were significantly associated with HPV vaccination (p < 0.05). Conclusion. HPV vaccination coverage remains suboptimal in West Cameroon. Strengthening public awareness, increasing healthcare provider involvement, implementing school-based vaccination programs, and improving vaccine availability could enhance vaccine uptake and contribute to cervical cancer prevention.
RÉSUMÉ
Introduction. La vaccination contre le virus du papillome humain (HPV) constitue la principale stratégie de prévention du cancer du col de l'utérus. Cependant, la couverture vaccinale demeure faible au Cameroun. Cette étude visait à identifier les obstacles perçus par les femmes à la vaccination contre le HPV chez les jeunes filles âgées de 9 à 14 ans et à proposer des stratégies pour améliorer l'adhésion vaccinale dans les districts de santé de Dschang et de Foumbot. Méthodes. Une étude transversale quantitative a été menée d'août 2025 à janvier 2026 auprès de 110 mères ou tutrices de jeunes filles âgées de 9 à 14 ans. Les données ont été recueillies par entretiens individuels à l'aide d'un questionnaire semi-structuré prétesté, puis analysées sous RStudio au moyen de statistiques descriptives et du test du chi-deux de Pearson, avec un seuil de signification statistique fixé à p < 0,05. Résultats. Dans l'ensemble, 60 % des participantes ont déclaré que leurs filles n'avaient pas reçu le vaccin contre le HPV. Les principaux obstacles identifiés étaient le manque d'information (21,8 %), les craintes concernant la sécurité du vaccin (30,9 %), les croyances culturelles ou religieuses, la distance jusqu'aux centres de vaccination (36,4 %) et l'indisponibilité du vaccin (34,6 %). La recommandation par un personnel de santé constituait le facteur majeur influençant la décision de vaccination (40 %). Les programmes de vaccination en milieu scolaire (56,4 %) et le renforcement des campagnes de sensibilisation (65,5 %) étaient les stratégies les plus fréquemment proposées pour améliorer la couverture vaccinale. Un niveau d'information plus élevé, les échanges avec les professionnels de santé et un meilleur accès aux services de vaccination étaient significativement associés à la vaccination contre le HPV (p < 0,05). Conclusion. La couverture vaccinale contre le HPV reste suboptimale dans l'Ouest-Cameroun. Le renforcement de la sensibilisation du public, une plus grande implication du personnel de santé, la mise en œuvre de programmes de vaccination en milieu scolaire et l'amélioration de la disponibilité des vaccins pourraient accroître l'adhésion vaccinale et contribuer à la prévention du cancer du col de l'utérus.

Keywords

Human papillomavirus (HPV) vaccination; Cervical cancer; Vaccine hesitancy; Barriers to vaccination; School-based vaccination; Cameroon Vaccination contre le virus du papillome humain (HPV) ; Cancer du col de l'utérus ; Hésitation vaccinale ; Obstacles à la vaccination ; Vaccination en milieu scolaire ; Cameroun

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Kamala Gumete Bienvenu Nkissi, Calvin Ebai Bisong, & Flore Nguemaïm. (2026). Perceived Barriers and Strategies to Improve HPV Vaccine Uptake: A Survey of Mothers in Dschang and Foumbot, Cameroon : Barrières Perçues et Stratégies pour Améliorer l’Adhésion au Vaccin HPV : Une Enquête Auprès des Mères à Dschang et Foumbot, Cameroun. HEALTH SCIENCES AND DISEASE, 27(10), 26–36. https://doi.org/10.67260/hsd.v27i10.7900
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Mapoko BSE, Mayeh AMM, Mapenya RRM, Mbassi EDB, Okobalemba EA, Sango AJF, et al. Aspects épidémiologiques et cliniques des cancers du col de l’utérus au Cameroun: expérience de l’Hôpital Général de Douala. Pan Afr Med J. 2022 ;42:109. doi:10.11604/pamj.2022.42.109.30704
  2. 2. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol.2002;3(1):11 6. doi:10.1016/s1470-2045(01)00617-9 PubMed PMID: 11905599.
  3. 3. Ellingson MK, Sheikha H, Nyhan K, Oliveira CR, Niccolai LM. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Hum Vaccines Immunother. 2023;19(2):2239085. doi:10.1080/21645515.2023.2239085
  4. 4. OMS. Stratégie mondiale en vue d’accélérer l’élimination du cancer du col de l’utérus en tant que problème de santé publique. 2020. Disponible sur: https://www.who.int/fr/publications/i/item/9789240014107
  5. 5. Ilic I, Ilic M. Human Papillomavirus Vaccination Coverage Estimates Among the Primary Target Cohort (9–14-Year-Old Girls) in the World (2010–2024). Vaccines. 27 sept 2025 ;13(10):1010. doi :10.3390/vaccines13101010
  6. 6. Han J, Zhang L, Chen Y, Zhang Y, Wang L, Cai R, et al. Global HPV vaccination programs and coverage rates: a systematic review. EClinicalMedicine. juin 2025 ;84:103290. doi: 10.1016/j.eclinm.2025.103290
  7. 7. Elit L, Manjuh F, Kila L, Suika B, Sinou M, Bozy E, et al. Mother–Child Approach to Cervical Cancer Prevention in a Low Resource Setting: The Cameroon Baptist Convention Health Services Story. Curr Oncol. 3 juin 2024;31(6):3227 38. doi:10.3390/curroncol31060244
  8. 8. World Bank. World Bank Blogs. 2024. Preventing cervical cancer in Africa: Why scaling HPV vaccination is a priority. Disponible sur: https://blogs.worldbank.org/en/health/Preventing-cervical-cancer-in-Africa-Why-scaling-HPV-vaccination-priority
  9. 9. Elit L, Ngalla C, Afugchwi GM, Tum E, Fokom Domgue J, Nouvet E. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9-14 years in rural communities of Northwest Cameroon: a qualitative study. BMJ Open. 15 nov 2022;12(11):e068212. doi:10.1136/bmjopen-2022-068212
  10. 10. Missii Banga E, Aimée. Evaluation de la prévention globale du cancer du col de l’utérus à Yaoundé [Thesis]. Université de Yaoundé I; 2023. Disponible sur: https://dicames.online/jspui/handle/20.500.12177/11369
  11. 11. Ngodem VCK, Ketchaji A, Sawi PCM, Magne MT, Ndjimafo TMM, Yanguem LL, et al. Factors associated with cervical cancer screening among women attending gynecological consultations at the Maroua Regional Hospital, Cameroon. Glob Health Econ Sustain. 6 nov 2024;0(0):0. doi:10.36922/ghes.4080
  12. 12. Ntonifor MMN, Tazinkeng NN, Kemah BL, Claudia NE, Sonia YK, Nchinjoh SC, et al. Factors associated with parental hesitancy towards the human papillomavirus vaccine: a cross-sectional study. Sci Rep. 26 mai 2025;15(1):18284. doi:10.1038/s41598-025-94067-1
  13. 13. Mayoudom Tagne PJ, Ketchaji A, Kegha Ngodem VC, Moyo Tachoum JR, Fodom Tchogang KC, Pokam Djoko GR. Cervical cancer screening and associated factors in women living with HIV followed at Bonassama District Hospital, Cameroon. J Public Health Res. oct 2025;14(4):22799036251401946. doi:10.1177/22799036251401946
  14. 14. Das JK, Salam RA, Arshad A, Lassi ZS, Bhutta ZA. Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations. J Adolesc Health. oct 2016;59(4 Suppl):S40 8. doi: 10.1016/j.jadohealth.2016.07.005
  15. 15. Marie, T. P., Appolinaire, A., Charlotte, N. T., Claudine, T. T., Gisele, K. F., & Zacharie, S. Epidémiologie de l’infection à HPV en Région semi-urbaine du Cameroun : L’expérience du District de Santé de Baham, Ouest-Cameroun. HEALTH SCIENCES AND DISEASE,2018 ; 19(1). https://doi.org/10.5281/hsd.v19i1.965
  16. 16. Dawud A, Kera AM, Bekele D, Hiko D, Zewdie A. Factors associated with uptake of human papillomavirus vaccination among adolescent girls in Mettu town, southwest Ethiopia: a school-based cross-sectional study. 1 nov 2023. doi:10.1136/bmjopen-2023-071878
  17. 17. 8. Isabirye A, Asiimwe JB, Mbonye KM. Factors associated with human papillomavirus vaccination uptake in Central Uganda. East Afr J Sci Technol Innov. 24 sept 2020;1(4). doi:10.37425/eajsti. v1i4.185
  18. 18. 9. Matranga D, Lumia C, Guarneri R, Arculeo VM, Noto M, Pivetti A, et al. The vaccinaTion & Hpv Knowledge (THinK) questionnaire: a reliability and validity study on a sample of women living in Sicily (southern-Italy). PeerJ. 9 mai 2019;7:e6254. doi:10.7717/peerj.6254 PubMed PMID: 31119063; PubMed Central PMCID: PMC6511389.
  19. 19. 10. Tiwana MH, Smith J. Faith and vaccination: a scoping review of the relationships between religious beliefs and vaccine hesitancy. BMC Public Health. 6 juill 2024; 24:1806. doi:10.1186/s12889-024-18873-4
  20. 20. 11. Gopalan RB, Babu BV, Sarma S K, John RP. Adverse Effects Following Immunisation and Vaccine Hesitancy: A Qualitative Study in a South Indian District. Drug Healthc Patient Saf. 16 juin 2025; 17:145‑56. doi:10.2147/DHPS.S515064
  21. 21. 12. Essa-Hadad J, Gorelik Y, Vervoort J, Jansen D, Edelstein M. Understanding the health system barriers and enablers to childhood MMR and HPV vaccination among disadvantaged, minority or underserved populations in middle- and high-income countries: a systematic review. Eur J Public Health. 3 avr 2024;34(2):368‑74. doi:10.1093/eurpub/ckad232
  22. 22. 13. AlShamlan NA, AlOmar RS, AlAbdulKader AM, Shafey MM, AlGhamdi FA, Aldakheel AA, et al. HPV Vaccine Uptake, Willingness to Receive, and Causes of Vaccine Hesitancy: A National Study Conducted in Saudi Arabia Among Female Healthcare Professionals. Int J Womens Health. 13 mars 2024; 16:463‑74. doi:10.2147/IJWH.S449979
  23. 23. 14. Fregnani JHTG, Carvalho AL, Eluf-Neto J, Ribeiro K de CB, Kuil L de M, Silva TA da, et al. A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study. PLOS ONE. 2013;8(4):e62647. doi: 10.1371/journal.pone.0062647
  24. 24. 15. Elenwo C, Batioja K, Davis T, Greiner BH, Markey C, Hartwell M. Associations of Maternal Age, Education, and Marital Status with HPV Vaccine Uptake and Hesitancy among United States Youth: A Cross-Sectional Analysis of the 2020 National Immunization Survey. J Pediatr Adolesc Gynecol. juin 2023;36(3):273‑9. doi: 10.1016/j.jpag.2023.01.213
  25. 25. 16. Santhanes D, Wong CP, Yap YY, San SP, Chaiyakunapruk N, Khan TM. Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): A scoping review. Hum Vaccines Immunother. 17 nov 2017;14(1):124‑33. doi:10.1080/21645515.2017.1381811
  26. 26. 17. Urrutia MT, Araya AX, Gajardo M, Chepo M, Torres R, Schilling A. Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary. Vaccines. 14 sept 2023;11(9):1486. doi:10.3390/vaccines11091486 PubMed PMID: 37766161; PubMed Central PMCID: PMC10536942.
  27. 27. 18. Vincent SC, Al Yaquobi S, Al Hashmi A. A Systematic Review of Knowledge, Attitudes, and Factors Influencing HPV Vaccine Acceptance Among Adolescents, Parents, Teachers, and Healthcare Professionals in the Middle East and North Africa (MENA) Region. Cureus. 2024;16(5):e60293. doi:10.7759/cureus.60293
  28. 28. 19. Kaul S, Do TQN, Hsu E, Schmeler KM, Montealegre JR, Rodriguez AM. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas. Papillomavirus Res. 22 oct 2019; 8:100189. doi: 10.1016/j.pvr.2019.100189
  29. 29. 20. Lim WT, Sears K, Smith LM, Liu G, Lévesque LE. Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. BMC Public Health. 3 oct 2014; 14:1029. doi:10.1186/1471-2458-14-1029
  30. 30. 21. Ledibane TD, Ledibane NR, Matlala M. Performance of the school-based human papillomavirus vaccine uptake in Tshwane, South Africa. South Afr J Infect Dis. 31 janv 2023;38(1):492. doi:10.4102/sajid. v38i1.492